{"DataElement":{"publicId":"3284567","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy Juvenile Myelomonocytic Leukemia Status Type","preferredDefinition":"A description of the best response to therapy for juvenile myelomonocytic leukemia.","longName":"2946463v1.0:2688819v1.1","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2946463","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Having the most positive qualities._The result of therapy for a given disease or condition in a patient or group of patients.","longName":"2404658v1.0:3194600v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3194600","version":"1","preferredName":"Best Outcome of Therapy","preferredDefinition":"Having the most positive qualities.:The result of therapy for a given disease or condition in a patient or group of patients.","longName":"C25432:C18919","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome of Therapy","conceptCode":"C18919","definition":"The result of therapy for a given disease or condition in a patient or group of patients.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D80CD45-BE7A-5B19-E040-BB89AD430E80","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-02","modifiedBy":"ONEDATA","dateModified":"2011-03-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"747EBAC6-25E8-A734-E040-BB89AD43588E","latestVersionIndicator":"Yes","beginDate":"2009-09-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2688819","version":"1.1","preferredName":"Juvenile Myelomonocytic Leukemia Status Type","preferredDefinition":"A myelodysplastic/myeloproliferative disease of childhood that is characterized by proliferation principally of the granulocytic and monocytic lineages.  Myelomonocytic proliferation is seen in the bone marrow and the blood.  The leukemic cells may infiltrate any tissue, however liver, spleen, lymph nodes, skin, and respiratory tract are the most common sites of involvement.  The prognosis is usually poor.  (WHO, 2001)_A condition or state at a particular time._Type; a subdivision of a particular kind of thing. [manually curated]","longName":"JMML_ST_TP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Progression to AML","valueDescription":"Progression to AML","ValueMeaning":{"publicId":"4241867","version":"1","preferredName":"Progression to AML","longName":"4241867","preferredDefinition":"Greater than or equal to 20% blasts in the bone marrow","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F50F2369-A42A-E6D0-E040-BB89AD434429","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50F2369-A442-E6D0-E040-BB89AD434429","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Disease relapse after achieving CR post-HSCT","valueDescription":"Recurrent Disease Post Complete Remission Hematopoietic Stem Cell Transplantation","ValueMeaning":{"publicId":"3284664","version":"1","preferredName":"Recurrent Disease Post Complete Remission Hematopoietic Stem Cell Transplantation","longName":"3284664","preferredDefinition":"the return of a sign, symptom, or disease after a remission.: Happening at a time subsequent to a reference time; later in time or order.: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.: Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.): The grafting of tissues from one individual to another or place to place within a single individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD9F740B-1B00-4D44-E040-BB89AD432571","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADD84387-FA93-7ED1-E040-BB89AD43541D","beginDate":"2011-09-26","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-26","modifiedBy":"ONEDATA","dateModified":"2011-09-26","deletedIndicator":"No"},{"value":"Persistent disease without progression","valueDescription":"Persistent Disease Without Disease Progression","ValueMeaning":{"publicId":"3284665","version":"1","preferredName":"Persistent Disease Without Disease Progression","longName":"3284665","preferredDefinition":"A disease that does not go to remission despite treatment.: Used to indicate the absence or lack of something or someone. (from Merriam-Webster OnLine): Cancer that continues to grow or spread.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Persistent Disease","conceptCode":"C90169","definition":"A disease that does not go to remission despite treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD9F740B-1B27-4D44-E040-BB89AD432571","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADD84387-FAA7-7ED1-E040-BB89AD43541D","beginDate":"2011-09-26","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-26","modifiedBy":"ONEDATA","dateModified":"2011-09-26","deletedIndicator":"No"},{"value":"CR after post-HSCT relapse","valueDescription":"Complete Remission Post Hematopoietic Stem Cell Transplantation Recurrent Disease","ValueMeaning":{"publicId":"3284663","version":"1","preferredName":"Complete Remission Post Hematopoietic Stem Cell Transplantation Recurrent Disease","longName":"3284663","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.: Happening at a time subsequent to a reference time; later in time or order.: Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.): The grafting of tissues from one individual to another or place to place within a single individual.: the return of a sign, symptom, or disease after a remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD9F740B-1AD7-4D44-E040-BB89AD432571","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADD84387-FABB-7ED1-E040-BB89AD43541D","beginDate":"2011-09-26","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-26","modifiedBy":"ONEDATA","dateModified":"2011-09-26","deletedIndicator":"No"},{"value":"Relapse","valueDescription":"Recurrent Disease","ValueMeaning":{"publicId":"3828963","version":"1","preferredName":"Recurrent Disease","longName":"3828963","preferredDefinition":"The return of a disease after a period of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2A8BB67-2BCE-B6D0-E040-BB89AD43093C","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"SOKKERL","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":"2023.1.20 Alt VM added per ticket request CADSR0001943. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50BD3CF-48EE-4A03-E040-BB89AD4342B3","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Continued complete remission (CCR)","valueDescription":"Continued Complete Response","ValueMeaning":{"publicId":"2688822","version":"1","preferredName":"Continued Complete Response","longName":"2688822","preferredDefinition":"The patient had achieved a complete response; received more therapy and continued in complete response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Continued Complete Response","conceptCode":"C70603","definition":"The patient had achieved a complete response; received more therapy and continued in complete response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C3CA061-0CB1-3BF6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50BD3CF-4902-4A03-E040-BB89AD4342B3","beginDate":"2007-10-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Complete remission (CR)","valueDescription":"Complete Remission","ValueMeaning":{"publicId":"2577915","version":"1","preferredName":"Complete Remission","longName":"2577915","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD68-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"ONEDATA","dateModified":"2006-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50BD3CF-490C-4A03-E040-BB89AD4342B3","beginDate":"2007-10-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Marginal response (MR)","valueDescription":"Marginal response","ValueMeaning":{"publicId":"4240420","version":"1","preferredName":"Marginal response","longName":"4240420","preferredDefinition":"Between 25% and 50% reduction in WBC and organomegaly - or - partial response in WBC but no\r\nchange in organomegaly - or - partial response in organomegaly but no change in WBC.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F50BD3CF-4916-4A03-E040-BB89AD4342B3","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50BD3CF-492E-4A03-E040-BB89AD4342B3","beginDate":"2011-12-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Minimal response (MR)","valueDescription":"Minimum Response","ValueMeaning":{"publicId":"2688821","version":"1","preferredName":"Minimum Response","longName":"2688821","preferredDefinition":"The smallest possible quantity.: Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimum","conceptCode":"C25570","definition":"The smallest possible quantity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C3CA061-0C75-3BF6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50BD3CF-4942-4A03-E040-BB89AD4342B3","beginDate":"2007-10-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Not assessed","valueDescription":"Not Assessed","ValueMeaning":{"publicId":"2688820","version":"1","preferredName":"Not Assessed","longName":"2688820","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Having determined the value, significance, or extent of.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C3CA061-0C4D-3BF6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50BD3CF-494C-4A03-E040-BB89AD4342B3","beginDate":"2007-10-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Not evaluable","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3153578","version":"1","preferredName":"Unevaluable","longName":"3153578","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93AC689E-5DB2-5D7A-E040-BB89AD430948","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-28","modifiedBy":"KUMMEROA","dateModified":"2023-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50BD3CF-4956-4A03-E040-BB89AD4342B3","beginDate":"2011-09-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Progressive disease (PD)","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"2559908","version":"1","preferredName":"Progressive Disease","longName":"2559908","preferredDefinition":"Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B711-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"HARTLEYG","dateModified":"2014-10-10","changeDescription":"Manually Curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50BD3CF-496A-4A03-E040-BB89AD4342B3","beginDate":"2007-10-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Partial remission (PR)","valueDescription":"Partial Remission","ValueMeaning":{"publicId":"2577916","version":"1","preferredName":"Partial Remission","longName":"2577916","preferredDefinition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD69-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"ONEDATA","dateModified":"2006-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50BD3CF-4974-4A03-E040-BB89AD4342B3","beginDate":"2007-10-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Stable disease (SD)","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2560100","version":"1","preferredName":"Stable Disease","longName":"2560100","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":"Manually curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50BD3CF-4988-4A03-E040-BB89AD4342B3","beginDate":"2007-10-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2688818","version":"1","preferredName":"Juvenile Myelomonocytic Leukemia Status Type","preferredDefinition":"A myelodysplastic/myeloproliferative disease of childhood that is characterized by proliferation principally of the granulocytic and monocytic lineages.  Myelomonocytic proliferation is seen in the bone marrow and the blood.  The leukemic cells may infiltrate any tissue, however liver, spleen, lymph nodes, skin, and respiratory tract are the most common sites of involvement.  The prognosis is usually poor.  (WHO, 2001) -- 2003:A condition or state at a particular time.:Type; a subdivision of a particular kind of thing.","longName":"C9233:C25688:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Juvenile Myelomonocytic Leukemia","conceptCode":"C9233","definition":"A clonal myeloid disorder of childhood previously classified as myelodysplastic/myeloproliferative neoplasm. It is characterized by the presence of monocytic proliferation in peripheral blood, less than 20% blasts in bone marrow and peripheral blood, splenomegaly, and the absence of BCR-ABL1 fusion. Almost all patients carry mutations of the RAS pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C3CA052-D196-2E22-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-11","modifiedBy":"ONEDATA","dateModified":"2007-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADD84387-FA1D-7ED1-E040-BB89AD43541D","latestVersionIndicator":"Yes","beginDate":"2007-10-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-26","modifiedBy":"KUMMEROA","dateModified":"2021-01-05","changeDescription":". 2021-1-5 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"},{"publicId":"3279253","version":"1","longName":"2115r1: Juvenile Myelomonocytic Leukemia (JMML / JCML) Post-HSCT Data","context":"NHLBI"}]}],"AlternateNames":[{"name":"jmml_post_bst_respns_hsct","type":"NMDP_FN","context":"NHLBI"},{"name":"JMMLpost_jmml_best_resp","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the best response of","type":"Preferred Question Text","description":"What was the best response of Juvenile Myelomonocytic Leukemia to transplant?","url":null,"context":"NHLBI"},{"name":"What was the recipients best response to transplant?","type":"Alternate Question Text","description":"What was the recipients best response to transplant?","url":null,"context":"NHLBI"},{"name":"What was the best response to HSCT?","type":"Alternate Question Text","description":"What was the best response to HSCT?","url":null,"context":"NHLBI"},{"name":"What was the best response to HCT?","type":"Alternate Question Text","description":"What was the best response to HCT?","url":null,"context":"NHLBI"},{"name":"What was the best response to HCT?","type":"Application Standard Question Text","description":"What was the best response to HCT?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD9D5B4D-781B-E9D5-E040-BB89AD436AE8","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-05","changeDescription":". 2021-1-5 ak OK to release per WZ. System generated def displayed as alt def. AK 11/17/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}